GE Healthcare Technologies Inc
GEHC
View Detailed Chart
73.730USD
+0.010+0.01%
Close 08/29, 16:00（ET）Quotes delayed by 15 min
33.66BMarket Cap
15.42P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+0.01%
5 Days
-1.98%
1 Month
+3.38%
6 Months
-15.59%
Year to Date
-5.69%
1 Year
-13.07%
View Detailed Chart
TradingKey Stock Score
Currency: USD Updated：2025-08-29Key Insights
The company's fundamentals are relatively healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
21
analysts
Buy
Current Rating
87.009
Target Price
+18.01%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
Fairly Valued
The company’s latest is 15.02, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 369.63M shares, decreasing 13.59% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 51.90M shares of this stock.
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
Ticker SymbolGEHC
CompanyGE Healthcare Technologies Inc
CEOMr. Kevin Michael O'Neill
Websitehttps://www.gehealthcare.com
Related Instruments
+0.65%
-0.12%
-0.19%
+0.38%
+0.16%
-1.08%
-0.31%
+0.66%
+0.04%
+1.44%
+0.80%
+0.75%
+1.00%
-0.87%
+1.55%
-1.51%
+0.42%
+0.10%
+2.46%
-2.07%
